Niels Grarup

Niels Grarup

Auto-generated profile, based on publicly available information

Niels Grarup

Novo Nordisk Foundation Center for Basic Metabolic Research, Faculty of Health and Medical Sciences, University of Copenhagen, 2200 Copenhagen, Denmark

Research Focus & Metrics

Academic Career Length

26Years (2001-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 August 2013 in Nature
Verified
Journal Article
Closed access
PDF file
ECEmmanuelle Le Chatelier
Emmanuelle Le Chatelier
TNTrine Nielsen
Trine Nielsen
JQJunjie Qin
Junjie Qin
EPEdi Prifti
Edi Prifti
FHFalk Hildebrand
Falk Hildebrand
OPOluf Pedersen
Oluf Pedersen

17 January 2010 in Nature Genetics
Verified
Journal Article
Open access
PDF file
JDJosée Dupuis
Josée Dupuis
CLClaudia Langenberg
Claudia Langenberg
IPInga Prokopenko
Inga Prokopenko
RSRicha Saxena
Richa Saxena
NSNicole Soranzo
Nicole Soranzo
IBInês Barroso
Inês Barroso
The MAGIC investigators report results of a large genome-wide association study meta-analysis to identify common variants influencing fasting glucose homeostasis. They further show that several of the newly discovered loci influencing glycemic traits are also associated with risk of type 2 diabetes. Levels of circulating glucose are tightly regulated. To identify new loci influencing glycemic traits, we performed meta-analyses of 21 genome-wide association studies informative for fasting glucose, fasting insulin and indices of beta-cell function (HOMA-B) and insulin resistance (HOMA-IR) in up to 46,186 nondiabetic participants. Follow-up of 25 loci in up to 76,558 additional subjects identified 16 loci associated with fasting glucose and HOMA-B and two loci associated with fasting insulin and HOMA-IR. These include nine loci newly associated with fasting glucose (in or near ADCY5, MADD, ADRA2A, CRY2, FADS1, GLIS3, SLC2A2, PROX1 and C2CD4B) and one influencing fasting insulin and HOMA-IR (near IGF1). We also demonstrated association of ADCY5, PROX1, GCK, GCKR and DGKB-TMEM195 with type 2 diabetes. Within these loci, likely biological candidate genes influence signal transduction, cell proliferation, development, glucose-sensing and circadian regulation. Our results demonstrate that genetic studies of glycemic traits can identify type 2 diabetes risk loci, as well as loci containing gene variants that are associated with a modest elevation in glucose levels but are not associated with overt diabetes.

8 October 2018 in Nature Genetics
Verified
Journal Article
Open access
PDF file
AMAnubha Mahajan
Anubha Mahajan
DTDaniel Taliun
Daniel Taliun
MTMatthias Thurner
Matthias Thurner
NRNeil R. Robertson
Neil R. Robertson
JTJason M. Torres
Jason M. Torres
MMMark I. McCarthy
Mark I. McCarthy
We expanded GWAS discovery for type 2 diabetes (T2D) by combining data from 898,130 European-descent individuals (9% cases), after imputation to high-density reference panels. With these data, we (i) extend the inventory of T2D-risk variants (243 loci, 135 newly implicated in T2D predisposition, comprising 403 distinct association signals); (ii) enrich discovery of lower-frequency risk alleles (80 index variants with minor allele frequency 2); (iii) substantially improve fine-mapping of causal variants (at 51 signals, one variant accounted for >80% posterior probability of association (PPA)); (iv) extend fine-mapping through integration of tissue-specific epigenomic information (islet regulatory annotations extend the number of variants with PPA >80% to 73); (v) highlight validated therapeutic targets (18 genes with associations attributable to coding variants); and (vi) demonstrate enhanced potential for clinical translation (genome-wide chip heritability explains 18% of T2D risk; individuals in the extremes of a T2D polygenic risk score differ more than ninefold in prevalence).

27 June 2010 in Nature Genetics
Verified
Journal Article
Closed access
PDF file
TIThe MAGIC investigators
The MAGIC investigators
BVBenjamin F Voight
Benjamin F Voight
TCThe GIANT Consortium
The GIANT Consortium
LSLaura J Scott
Laura J Scott
VSValgerdur Steinthorsdottir
Valgerdur Steinthorsdottir
MMMark I McCarthy
Mark I McCarthy

30 March 2008 in Nature Genetics
Verified
Journal Article
Closed access
PDF file
EZEleftheria Zeggini
Eleftheria Zeggini
LSLaura J. Scott
Laura J. Scott
RSRicha Saxena
Richa Saxena
BVBenjamin F. Voight
Benjamin F. Voight
JMJonathan L Marchini
Jonathan L Marchini
DADavid Altshuler
David Altshuler

9 December 2021 in Nature
Verified
Journal Article
Closed access
PDF file
SGSarah E. Graham
Sarah E. Graham
SCShoa L. Clarke
Shoa L. Clarke
KWKuan-Han H. Wu
Kuan-Han H. Wu
Stavroula KanoniStavroula Kanoni
Stavroula Kanoni
GZGreg J. M. Zajac
Greg J. M. Zajac
CWCristen J. Willer
Cristen J. Willer